J. Weber

发表

of Cyclin D1 by the SCF FBX4-aB Crystallin Complex

J. Harper, A. Rustgi, S. Fuchs, 2006 .

Phosphorylation-Dependent Ubiquitination of Cyclin D1 by the SCFFBX4-αB Crystallin Complex

A. Klein-Szanto, J. Harper, A. Rustgi, 2006 .

Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis

B. Faubert, Russell G. Jones, D. O’Sullivan, 2013, Cell.

Whole Genome Analysis Informs Breast Cancer Response to Aromatase Inhibition

Joshua F. McMichael, Christopher A. Miller, Joshua M. Stuart, 2012, Nature.

Synthetic lethality through combined Notch-epidermal growth factor receptor pathway inhibition in basal-like breast cancer.

Yiyu Dong, Jianbo Wang, J. Weber, 2010, Cancer research.

Nucleophosmin Is Essential for Ribosomal Protein L5 Nuclear Export

M. Dai, Hua Lu, J. Weber, 2006, Molecular and Cellular Biology.

Nucleophosmin Serves as a Rate-Limiting Nuclear Export Chaperone for the Mammalian Ribosome

P. Pandolfi, J. Weber, R. Townsend, 2008, Molecular and Cellular Biology.

Phosphorylation-dependent ubiquitination of cyclin D1 by the SCF(FBX4-alphaB crystallin) complex.

A. Klein-Szanto, J. Harper, A. Rustgi, 2006, Molecular cell.

Associations of race and ethnicity with risk of developing invasive breast cancer after lobular carcinoma in situ

Y. Liu, G. Colditz, F. Ademuyiwa, 2019, Breast Cancer Research.

A Non-Tumor Suppressor Role for Basal p19ARF in Maintaining Nucleolar Structure and Function

A. Hirbe, J. Weber, L. Maggi, 2007, Molecular and Cellular Biology.

Upregulation of 5′-terminal oligopyrimidine mRNA translation upon loss of the ARF tumor suppressor

Kyle A. Cottrell, J. Weber, Ryan C. Chiou, 2020, Scientific Reports.

RNA helicase DDX5 is a p53-independent target of ARF that participates in ribosome biogenesis.

Jianbo Wang, R. Kladney, J. Weber, 2011, Cancer research.

Molecular and Cellular Pathobiology RNAHelicase DDX 5 Is a p 53-Independent Target of ARF That Participates in Ribosome Biogenesis

Jianbo Wang, R. Kladney, J. Weber, 2011 .

The ARF Tumor Suppressor Regulates Bone Remodeling and Osteosarcoma Development in Mice

T. Rosol, L. Ratner, J. Harding, 2010, PloS one.

TSC1 sets the rate of ribosome export and protein synthesis through nucleophosmin translation.

D. Gutmann, J. Weber, L. Maggi, 2007, Cancer research.

Fibronectin and cytokines increase JNK, ERK, AP-1 activity, and transin gene expression in rat hepatic stellate cells.

B. Bacon, J. Baldassare, J. Weber, 1997, American journal of physiology. Gastrointestinal and liver physiology.

Nucleophosmin redistribution following heat shock: a role in heat-induced radiosensitization.

C. Hunt, J. Weber, R. Vanderwaal, 2009, Cancer research.

Evaluation of Racial/Ethnic Differences in Treatment and Mortality Among Women With Triple-Negative Breast Cancer.

G. Colditz, J. Weber, M. Lian, 2021, JAMA oncology.

Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer

Alex H. Wagner, Zachary L. Skidmore, R. Wilson, 2018, Nature Communications.

DHX33 Transcriptionally Controls Genes Involved in the Cell Cycle

J. Weber, Chunyan Fan, Hanbing Zhong, 2016, Molecular and Cellular Biology.

Oncogenic Ras induces p19ARF and growth arrest in mouse embryo fibroblasts lacking p21Cip1 and p27Kip1 without activating cyclin D-dependent kinases.

M. Roussel, C. Sherr, J. Weber, 2000, The Journal of biological chemistry.

, rRNA Synthesis and Cell Growth Identification of DHX 33 as a Mediator of

J. Weber, Alexander P. Miceli, Jason T. Forys, 2011 .

Identification of DHX33 as a Mediator of rRNA Synthesis and Cell Growth

J. Weber, Alexander P. Miceli, Jason T. Forys, 2011, Molecular and Cellular Biology.

8-Azaadenosine and 8-Chloroadenosine are not Selective Inhibitors of ADAR

Kyle A. Cottrell, J. Weber, Luis Torres, 2021, bioRxiv.

Nucleophosmin mediates mammalian target of rapamycin-dependent actin cytoskeleton dynamics and proliferation in neurofibromin-deficient astrocytes.

D. Gutmann, J. Weber, B. Hegedűs, 2007, Cancer research.

Ablation of Goα Overrides G1Restriction Point Control through Ras/ERK/Cyclin D1-CDK Activities*

J. Baldassare, J. Weber, D. Raben, 1997, The Journal of Biological Chemistry.

DHX33 Interacts with AP-2β To Regulate Bcl-2 Gene Expression and Promote Cancer Cell Survival

J. Weber, Zhen Yuan, Weimin Feng, 2019, Molecular and Cellular Biology.

p53-independent functions of the p19 tumor suppressor

M. Roussel, J. Rehg, G. Lozano, 2000 .

Fibronectin and cytokines increase JNK, ERK, AP-1 activity, and transin gene expression in rat hepatic stellate cells.

B. Bacon, J. Baldassare, J. Weber, 1997, The American journal of physiology.

Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma.

D. Gutmann, J. Weber, B. Dasgupta, 2005, Cancer research.

Identiﬁcation of DHX33 as a Mediator of rRNA Synthesis and Cell Growth (cid:1)

J. Weber, Alexander P. Miceli, Jason T. Forys, 2011 .

A faster migrating variant masquerades as NICD when performing in vitro gamma-secretase assays with bacterially expressed Notch substrates.

Raphael Kopan, D. Cistola, J. Weber, 2006, Biochemistry.

Ablation of Go α-Subunit Results in a Transformed Phenotype and Constitutively Active Phosphatidylcholine-specific Phospholipase C*

J. Baldassare, J. Weber, D. Raben, 1997, The Journal of Biological Chemistry.

Mitochondrial fusion supports increased oxidative phosphorylation during cell proliferation

G. Patti, J. Weber, Cong-Hui Yao, 2019, eLife.

Deacetylation of the retinoblastoma tumour suppressor protein by SIRT1.

J. Weber, Sharon Wong, 2007, The Biochemical journal.

Solution structure of the p53 regulatory domain of the p19Arf tumor suppressor protein.

R. Kriwacki, B. Bothner, J. Weber, 2001, Biochemistry.

Defining the molecular basis of Arf and Hdm2 interactions.

R. Kriwacki, B. Bothner, J. Weber, 2001, Journal of molecular biology.

Nucleolar Arf sequesters Mdm2 and activates p53

Charles J. Sherr, Martine F. Roussel, M. Roussel, 1999, Nature Cell Biology.

Nucleolar Adaptation in Human Cancer

J. Weber, L. Maggi, 2005, Cancer investigation.

PIK3CA and PIK3CB inhibition produce synthetic lethality when combined with estrogen deprivation in estrogen receptor-positive breast cancer.

J. Olson, C. Perou, M. Ellis, 2009, Cancer research.

ARF tumor suppression in the nucleolus.

J. Weber, L. Maggi, Anthony J. Apicelli, 2014, Biochimica et biophysica acta.

The ARF tumor suppressor controls Drosha translation to prevent Ras-driven transformation

J. Weber, Michael Kuchenreuther, 2013, Oncogene.

Elevated DDX21 regulates c-Jun activity and rRNA processing in human breast cancers

J. Weber, A. Saporita, Yandong Zhang, 2014, Breast Cancer Research.

Elevated DDX 21 regulates c-Jun activity and rRNA processing in human breast cancers

J. Weber, A. Saporita, Yandong Zhang, 2014 .

ARF and p 53 coordinate tumor suppression of an oncogenic IFN-β-STAT 1-ISG 15 signaling axis

J. Weber, L. Maggi, Jason T. Forys, 2016 .

ARF and p53 coordinate tumor suppression of an oncogenic IFN-β-STAT1-ISG15 signaling axis.

J. Weber, L. Maggi, Jason T. Forys, 2014, Cell reports.

Cooperative Signals Governing ARF-Mdm2 Interaction and Nucleolar Localization of the Complex

M. Roussel, R. Kriwacki, C. Sherr, 2000, Molecular and Cellular Biology.

Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors.

D. Gutmann, J. Weber, B. Dasgupta, 2005, Cancer research.

The Role of RNA Editing in Cancer Development and Metabolic Disorders

J. Weber, L. Maggi, Che-Pei Kung, 2018, Front. Endocrinol..

Nucleolar Disruption Ensures Nuclear Accumulation of p21 upon DNA Damage

O. Bachs, N. Agell, M. Berciano, 2010, Traffic.

Deconvoluting mTOR biology

D. Gutmann, J. Weber, 2012, Cell cycle.

It’s Getting Complicated—A Fresh Look at p53-MDM2-ARF Triangle in Tumorigenesis and Cancer Therapy

J. Weber, Che-Pei Kung, 2022, Frontiers in Cell and Developmental Biology.

Aberrant NPM Expression during Nf1Loss and Its Role in Promoting Proliferation

J. Weber, 2006 .

the Action Is Forget Transcription: Translation Is Where

J. Weber, L. Maggi, Leonard Maggi, 2013 .

Macrophage proliferation machinery leads to PDAC progression, but susceptibility to innate immunotherapy

K. Lim, J. Weber, R. Fields, 2021 .

p19ARF and RasV12 Offer Opposing Regulation of DHX33 Translation To Dictate Tumor Cell Fate

J. Weber, A. Saporita, Yandong Zhang, 2013, Molecular and Cellular Biology.

Neurofibromin-Deficient Astrocytes Dependent Actin Cytoskeleton Dynamics and Proliferation in − Nucleophosmin Mediates Mammalian Target of Rapamycin

D. Gutmann, J. Weber, B. Hegedűs, 2007 .

Knocking down nucleolin expression in gliomas inhibits tumor growth and induces cell cycle arrest

D. Piwnica-Worms, S. Dahiya, J. Weber, 2012, Journal of Neuro-Oncology.

Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase.

J. Baldassare, J. Weber, D. Raben, 1997, The Biochemical journal.

Race and risk of subsequent aggressive breast cancer following ductal carcinoma in situ

R. West, Y. Liu, G. Colditz, 2019, Cancer.

Loss of Trop 2 Promotes Carcinogenesis and Features of Epithelial to Mesenchymal Transition in Squamous Cell Carcinoma

P. Humphrey, C. Chung, J. Arbeit, 2011 .

PIK 3 CA and PIK 3 CB Inhibition Produce Synthetic Lethality when Combined with Estrogen Deprivation in Estrogen Receptor – Positive Breast Cancer

J. Olson, C. Perou, M. Ellis, 2009 .

Renewing the debate over the p53 apoptotic response

G. Zambetti, J. Weber, 2003, Cell Death and Differentiation.

ADAR1 editing dependency in triple-negative breast cancer

Kyle A. Cottrell, R. Kladney, J. Weber, 2020, bioRxiv.

Ras-stimulated Extracellular Signal-related Kinase 1 and RhoA Activities Coordinate Platelet-derived Growth Factor-induced G1 Progression through the Independent Regulation of Cyclin D1 and p27KIP1 *

J. Baldassare, J. Weber, D. Raben, 1997, The Journal of Biological Chemistry.

Loss of Trop2 Promotes Carcinogenesis and Features of Epithelial to Mesenchymal Transition in Squamous Cell Carcinoma

P. Humphrey, C. Chung, J. Arbeit, 2011, Molecular Cancer Research.

Cancer Genes and Genomics Loss of Trop 2 Promotes Carcinogenesis and Features of Epithelial to Mesenchymal Transition in Squamous Cell Carcinoma

P. Humphrey, C. Chung, J. Arbeit, 2011 .

Tuberous sclerosis complex 1: an epithelial tumor suppressor essential to prevent spontaneous prostate cancer in aged mice.

R. Cardiff, J. Arbeit, D. Kwiatkowski, 2010, Cancer research.

Hypergrowth mTORC1 Signals Translationally Activate the ARF Tumor Suppressor Checkpoint

J. Weber, Alexander P. Miceli, A. Saporita, 2011, Molecular and Cellular Biology.

Understanding and Targeting Cell Growth Networks in Breast Cancer

J. Weber, 2010 .

Functional Cell Biology: An Overview

Y. Yarden, Michael Loran Dustin, J. Weber, 2016 .

ARF Impedes NPM/B23 Shuttling in an Mdm2-Sensitive Tumor Suppressor Pathway

J. Weber, L. Maggi, Jason D. Weber, 2004, Molecular and Cellular Biology.

ARF suppresses 5’-terminal oligopyrimidine mRNA translation

Kyle A. Cottrell, J. Weber, Ryan C. Chiou, 2020, bioRxiv.

and Function in Maintaining Nucleolar Structure ARF p19Suppressor Role for Basal

A. Hirbe, J. Weber, L. Maggi, 2014 .

Synergistic Effects of Concurrent Blockade of PI3K and MEK Pathways in Pancreatic Cancer Preclinical Models

F. Gao, C. Sanchez, A. Lockhart, 2013, PloS one.

Stromal and therapy-induced macrophage proliferation promotes PDAC progression and susceptibility to innate immunotherapy

D. Zhou, K. Lim, J. Weber, 2023, The Journal of experimental medicine.

Evaluating the therapeutic potential of ADAR1 inhibition for triple-negative breast cancer

Kyle A. Cottrell, R. Kladney, J. Weber, 2020, Oncogene.

Induction of viral mimicry upon loss of DHX9 and ADAR1 in breast cancer cells

Kyle A. Cottrell, J. Weber, Sua Ryu, 2023 .

TP53 Mutations and Lung Cancer: Not All Mutations Are Created Equal

R. Govindan, J. Weber, 2014, Clinical Cancer Research.

Cathepsin K-Cre Causes Unexpected Germline Deletion of Genes in Mice

R. Kladney, J. Weber, L. Maggi, 2012, PloS one.

c-Fms Tyrosine 559 Is a Major Mediator of M-CSF-induced Proliferation of Primary Macrophages*

R. Faccio, S. Takeshita, S. Teitelbaum, 2007, Journal of Biological Chemistry.

Sabotaging of the oxidative stress response by an oncogenic noncoding RNA

J. Licht, M. Tomasson, J. Weber, 2017, The FASEB Journal.

Abstract LB-298: The multiple-myeloma associated snoRNA, ACA11 increases oxidative stress and cell proliferation

M. Tomasson, J. Weber, L. Maggi, 2015 .

Therapeutic targets in the ARF tumor suppressor pathway.

J. Weber, L. Maggi, Anthony J. Apicelli, 2007, Current medicinal chemistry.

Targeting PTEN-defined breast cancers with a one-two punch

J. Weber, L. Maggi, 2015, Breast Cancer Research.

The DHX33 RNA Helicase Promotes mRNA Translation Initiation

J. Weber, Yandong Zhang, Xingshun Wang, 2015, Molecular and Cellular Biology.

The ARF/p53 pathway.

J. D. Weber, C. Sherr, J. Weber, 2000, Current opinion in genetics & development.

Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.

M. Roussel, J. Cleveland, C. M. Eischen, 1999, Genes & development.

Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2.

F. Zindy, M. Roussel, G. Zambetti, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Associations of race and ethnicity with risk of developing invasive breast cancer after lobular carcinoma in situ

Y. Liu, G. Colditz, F. Ademuyiwa, 2019, Breast Cancer Research.

p53-independent functions of the p19(ARF) tumor suppressor.

M. Roussel, J. Rehg, G. Lozano, 2000, Genes & development.

Mammalian target of rapamycin: master regulator of cell growth in the nervous system.

D. Gutmann, J. Weber, D. Sandsmark, 2007, Histology and histopathology.

Author response: Mitochondrial fusion supports increased oxidative phosphorylation during cell proliferation

G. Patti, J. Weber, Cong-Hui Yao, 2018 .

Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2.

F. Zindy, M. Roussel, G. Zambetti, 1998, Proceedings of the National Academy of Sciences of the United States of America.

RNA helicase DDX5 is a p53-independent target of ARF that participates in ribosome biogenesis.

Jianbo Wang, R. Kladney, J. Weber, 2011, Cancer research.

Deconvoluting mTOR biology

D. Gutmann, J. Weber, 2012, Cell cycle.

Tuberous sclerosis complex 1: an epithelial tumor suppressor essential to prevent spontaneous prostate cancer in aged mice.

R. Cardiff, J. Arbeit, D. Kwiatkowski, 2010, Cancer research.

TP53 Mutations and Lung Cancer: Not All Mutations Are Created Equal

R. Govindan, J. Weber, 2014, Clinical Cancer Research.

Forget Transcription: Translation Is Where the Action Is

J. Weber, Leonard Maggi, 2013, Molecular and Cellular Biology.